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a b s t r a c t
Here we report successful thoracoscopic-assisted sclerotherapy of a large, prenatally diagnosed micro-
cystic thoracoabdominal lymphatic malformation in a 3-month-old infant born at 38 weeks gestational
age. Compression of the inferior vena cava and aortic displacement was demonstrated on imaging.
Treatment options include medical management, percutaneous sclerotherapy, or surgical resection. The
latter options were complicated by the location of this lesion. Therefore, sclerotherapy under direct
visualization via thoracoscopy was performed with near resolution of the lesion after one treatment. This
is the first description of treatment of a lymphatic malformation via this approach reported in the
literature.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
1. Case description
A routine second trimester ultrasound at 20 weeks gestational
age disclosed a large posterior mediastinal mass in a male fetus
during an otherwise uncomplicated pregnancy. This was followed
by term delivery at 38 þ 1 weeks gestational age. Abdominal
ultrasound on day of life 1 confirmed the presence of a large, well
circumscribed, “spongy” appearing mass in the posterior medias-
tinum (Fig. 1). Further characterization with MRI (Fig. 2a) and
contrast CT scan showed the mass to be in the left pleural space,
extending across the posteriormediastinum, and through the aortic
hiatus of the diaphragm into the retroperitoneum. The lesion dis-
placed the aorta posteriorly and rightward, the esophagus anteri-
orly, and significantly compressed the inferior vena cava. Lack of an
appreciable feeding artery or vein, or involvement of neural
foramina were additional findings most consistent with a micro-
cystic lymphatic malformation.
The patient was asymptomatic without signs of infection,
venous congestion, or ascites. Additionally, therewas no respiratory
or feeding difficulty noted and the patient was discharged with
close interval follow-up. A repeat ultrasound at 1 month of age
confirmed that the mass had not significantly changed in size,
echotexture, or displacement of surrounding structures.
Although the patient remained asymptomatic, the compression
of the vena cava and displacement of the aorta by this lymphatic
malformation were concerning, as in the event of hemorrhage or
infection, compression by mass effect could potentially be lethal.
Resection was considered, but given the potential for a large chy-
lothorax, enthusiasm for this as first line treatment was limited.
The proximity of this lymphatic malformation to critical thor-
acoabdominal structures raised concern for iatrogenic injury during
percutaneous sclerotherapy. The decision was made to perform
sclerotherapy under thoracoscopic visualization with a plan for
resection if this was not successful.
The patient was given 25 mg/kg cefazolin in addition to 0.1 mg/
kg dexamethasone preoperatively to mitigate the risk of post-
operative swelling and vascular occlusion. The operation was
performed via a left-sided thoracoscopic approach with the pa-
tient 45 up from prone. One 5 mm thoracoscopic port was placed
at the 6th intercostal space in the midaxillary line. After intro-
duction of CO2 pneumothorax to 6 mm Hg, a thoracoscope was
introduced and the mass immediately identified in the posterior
mediastinum. A 22 gauge spinal needle was inserted directly
through the chest wall at the 8th intercostal space in the posterior
axillary line. Attempts to aspirate the lymphatic malformation
were unsuccessful, likely due to its microcystic nature. 30 mL of
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a doxycycline 10 mg/mL solution was added to 7 mL of 0.25%
bupivacaine. A total dose of 83 mg, or 11 mg/kg of the doxycycline
was administered intra-lesionally in 4 sites in 10 mL aliquots. An
8-French pigtail catheter was placed through the trocar site and
removed the following day. The patient tolerated the procedure
well, required no narcotics post operatively and began breast-
feeding the night of surgery. He was discharged home after 36 h of
monitoring, doing well and without symptoms.
At his 2 and 4-week post-op follow-up appointments the patient
continued to do well. Follow-up MRI at 6 weeks post-op showed
significant reduction in size of the lymphatic malformation as well
as resolution of the vascular compression and displacement,
without evidence of effusion or ascites (Fig. 2b). The parents elected
not to proceed with further schlerotherapy given the significant
response.
2. Discussion
Congenital lymphatic malformations arise from dysembryo-
genesis of the lymphatic system in utero and include awide array of
pathologic and clinical manifestations. Pathologically these can be
characterized as combined lymphovascular malformations, isolated
cystic malformations, and congenital lymphedema. Using the 2014
ISSVA classification system, this patient’s lesion is most likely a
benign lymphatic malformation without additional syndrome-
associated anomaly [1]. Isolated cystic lymphatic malformations are
further classified as macrocystic, microcystic, or combined.
The combined incidence of lymphatic anomalies and lymphe-
dema in children is well less than 1%, roughly 0.14% by one report
though there is a paucity of literature addressing the true epide-
miology of these lesions [2]. There is no male vs. female predi-
lection, with ratio of approximately 1:1. Symptoms, complications,
and to some extent prognosis, are primarily related to anatomical
location and extent of involvement therein, with 45e52% occur-
ring in head and neck, followed by axilla, mediastinum, retro-
peritoneum, and groin [3]. Large isolated thoracoabdominal
Fig. 1. Abdominal ultrasound on day of life 1 shows a heterogeneously microcystic
structure surrounding the aorta (blue arrow, with vascular flow) and compressing the
retrohepatic vena cava (white arrow).
Fig. 2. Representative (a) pre and (b) post-sclerotherapy coronal and axial T2 fat suppressed MRI with contrast showing dramatic improvement after a single thoracoscopic-guided
injection of doxycycline.
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lymphatic malformations as described in the case above are
exceedingly rare [2,4].
Large cystic lesions are often diagnosed prenatally upon 2nd
trimester US, as in this case, and may influence the location and
timingof delivery. Still, themajority remaindiagnosed at birth [3]. On
ultrasonography, chyle is typically anechoic or hypoechoic. MRI will
allow better visualization of deep anatomic extent, and will show
perivascular T2 hyperintensity surrounding the aorta or iliac vessels
[5,6]. Macrocystic lesions tend to show multiple septations on
ultrasound with cysts of varying size compared to microcystic le-
sions, which are more uniform appearing as in our patient’s case [3].
The natural history of lymphatic malformations rarely involves
spontaneous resolution, most tend to grow with the patient if not
intervened upon [3,7]. Unmanaged growth of lymphatic malfor-
mations carries risk for infection, internal hemorrhage, lymphatic
or chylous leak, with additional risk of flow redirection or recur-
rence following operative intervention [3,8,9].
Therapeutic interventions vary depending on location, symp-
toms, and active or potential complications, with an increasing trend
toward nonoperative management up front using sclerotherapy or
medical management. Single agent medical management with
sirolimus shows the most promising results, used for various lym-
phovascular malformations, though this remains associated with
leukopenia and other systemic toxicities [10]. Percutaneous sclero-
therapy remains the most commonly used non-surgical manage-
ment technique for lymphaticmalformations.Microcystic lesions are
less responsive to sclerotherapy than theirmacrocystic counterparts,
and may require additional laser ablation or surgery [3,11,12].
Doxycycline, bleomycin, and OK-432 are the most commonly used
agents, and may require multiple injections for maximal resolution
depending on lesion size and complexity [8,9,11e18].
Primary resection is often anatomically difficult due to location,
proximity to critical structures, and lesions whose extent does not
respect fascial planes, further elevating their level of anatomic
complexity. For these reasons surgical resection may often be fol-
lowed by leak, recurrence, or redirection of lymphatic congestion.
Preoperative considerations include whether resection is being
performed for functional compromise, cosmesis, or both, and to
what extent either will be improved by the initial procedure versus
a staged approach to resection [3].
The most common post-operative complications of large thor-
acoabdominal lymphatic malformations are re-accumulation, and
leak with chylothorax or chylous ascites, which carries significant
potential morbidity in small infants [19]. Lymphatic malformations
often grow with associated ectatic veins, which may lead to spon-
taneous or traumatic internal hemorrhage. Infection, either iatro-
genic or due transient bacteremia may prove difficult to treat [3,18].
In this case, the decision to perform sclerotherapy under thor-
acoscopic guidance was made after considering the risks of all
treatment options, to include expectant management, in an
asymptomatic patient. As the response to one treatment resulted in
resolution of the compression of the great vessels, the parents
opted for close follow-up only after a single treatment. He has been
followed for several months and continues to well, without evi-
dence of re-accumulation on ultrasound.
3. Conclusion
We present a case of successful management of a microcystic
posterior mediastinal and retroperitoneal lymphatic malformation
treated with a single dose of doxycycline sclerotherapy injected
under thoracoscopic guidance.
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